灭活疫苗
Inactivated vaccines
4月11日,工作人员在国药集团中国生物新冠疫苗生产基地质量检定部门对新型冠状病毒灭活疫苗样品进行纯度检测。新华社记者张玉薇 摄 图源:新华网
据新华社报道,国务院联防联控机制科研攻关组14日表示,我国两款新冠病毒灭活疫苗获得国家药品监督管理局一二期合并的临床试验许可,相关临床试验同步启动。这是首批获得临床研究批件的新冠病毒灭活疫苗。此次获批进入临床试验的灭活疫苗,可用于大规模接种,并且有国际通行标准来判断疫苗的安全性和有效性。
China has approved two COVID-19 inactivated vaccine candidates for clinical trials, according to the State Council joint prevention and control mechanism against the coronavirus Tuesday. The two vaccines are China's first batch of inactivated vaccines for COVID-19 that have obtained clinical trial approval. They can be used for large-scale vaccination, and their safety and effectiveness can be judged by internationally accepted standards.
综合来源:新华网